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Background: The purpose of this study was to evaluate the effect of low-frequency self-administered 33 
vibration therapy into myofascial trigger points in the upper trapezius and levator scapulae on patients 34 
with chronic non-specific neck pain. 35 
Methods: Twenty-eight patients with chronic non-specific neck pain were randomly assigned into a 36 
vibration group, receiving 10 self-applied sessions of vibration therapy in the upper trapezius and levator 37 
scapulae trigger points; or a control group, receiving no intervention. Self-reported neck pain and 38 
disability (Neck Disability Index) and pressure pain threshold were assessed at baseline and after the first, 39 
fifth and 10th treatment sessions. 40 
Findings: Significant differences were found in the vibration group when compared to the control group 41 
after the treatment period: the vibration group reached lower Neck Disability Index scores (F=4.74, P=.033, 42 
η2=0.07) and greater pressure pain threshold values (F=7.56, P=.01, η2=0.10) than the control group. The 43 
vibration group reported a significant reduction in Neck Disability Index scores (χ2=19,35, P=.00, Kendall's 44 
W=0.28) and an increase in pressure pain threshold (χ2=87,10, P=.00, Kendall's W=0.73) between the 45 
assessment times over the course of the treatment. The mean increase in pressure pain threshold in the 46 
vibration group after the 10 sessions was 8.54 N/cm2, while the mean reduction in Neck Disability Index 47 
scores was 4.53 points. 48 
Interpretation: Vibration therapy may be an effective intervention for reducing self-reported neck pain 49 
and disability and pressure pain sensitivity in patients with chronic non-specific neck pain. This tool 50 
could be recommended for people with non-specific neck pain. 51 
KEYWORDS 52 
Neck pain; Pain threshold; Rehabilitation; Trigger points; Vibration. 53 
ABBREVIATIONS 54 
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VT: Vibration therapy 56 
DOMS: Delayed onset muscle soreness 57 
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NDI: Neck Disability Index  60 
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1. INTRODUCTION 66 
Myofascial pain syndrome is defined as a cluster of signs and symptoms associated with active 67 
and latent myofascial trigger points (MTrPs). An MTrP is a hyperirritable focus within a taut band of 68 
skeletal muscle that is painful on compression and which, when stimulated, can evoke a characteristic 69 
pattern of referred pain and related autonomic phenomena [1]. 70 
MTrPs are a common source of regional pain in patients presenting with musculoskeletal pain. 71 
Indeed, the prevalence of MTrPs has been found to be up to 85% of the general population [2]. Sleeping 72 
posture is related to musculoskeletal disorders of the shoulder or neck [3]. Moreover, it is known that 73 
sleep disturbances are frequent among patients with neck pain [4, 5]. Specifically, poor cervical posture 74 
during sleep, which is believed to increase biomechanical stresses on the structure of the cervical spine, 75 
can produce cervical pain and stiffness, headache, and scapular or arm pain, resulting in low-quality sleep 76 
[3]. From a clinical point of view, MTrPs may be either active or latent. Active and latent MTrPs have 77 
similar physical manifestations, except that latent MTrPs do not elicit spontaneous symptoms and the 78 
local and referred pain reproduced by stimulating latent MTrPs is not familiar to the patient [6]. Active, 79 
but not latent, MTrPs have been recognized as a common cause of local musculoskeletal pain and 80 
dysfunction [6], but recent research has emphasized the importance of latent MTrPs both in diagnosis and 81 
treatment [7]. In addition, elimination of latent MTrPs is accompanied by normalization of impaired 82 
motor activation patterns [8]. 83 
Several treatment strategies have been suggested to treat MTrPs, ranging from conservative 84 
techniques such as massage [9], pressure release [10], ischemic compression [11, 12], and spray and 85 
stretch [13], to invasive interventions such as dry needling [12-15] or injections [16]. Within massage 86 
techniques, Swedish massage is probably the most commonly used among physical therapists. Massage 87 
has been claimed to promote relaxation and decrease tissue adhesion, increase intramuscular circulation 88 
[17, 18] and decrease neuromuscular excitability [17]. In addition, massage has been found to reduce 89 
myalgia symptoms by approximately 25% to 50% [19] and have preventive effects [20]. In fact, vibration 90 
massage applied for five minutes followed by kneading manoeuvres was the treatment proposed by 91 
Lindemann et al. [21] in the 1970s to reduce myogelosis, an expression synonymous with MTrPs. Despite 92 
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the extensive application of massage therapies, clinical trials investigating their efficacy in subjects with 93 
MTrPs are scarce [22]. 94 
In the last two decades, the use of mechanical vibration for rehabilitation purposes has attracted 95 
the interest of researchers [23, 24]. Vibration therapy (VT) is used to stimulate edema absorption, 96 
improve blood flow, alleviate wound healing and for its anti-inflammatory and antifibrous effects [25, 97 
26]. In addition, the effects of VT on pain relief have also been widely demonstrated. In particular, this 98 
technique has been shown to be beneficial for patients with fibromyalgia [22], acute and chronic 99 
musculoskeletal pain [27], delayed onset muscle soreness (DOMS) [24, 28], and myotendinous injuries 100 
that involve MTrPs [29]. Although previous studies have examined the use of massage techniques on 101 
patients with MTrPs [30, 31], to our knowledge there are no studies which have evaluated the 102 
effectiveness of VT on MTrPs. 103 
Self-management strategies are considered essential to the management of persistent 104 
musculoskeletal disorders such as neck pain [32]. Effective self-management is based on skills to 105 
encourage patients to actively participate in, and take responsibility for, common or persistent conditions 106 
[33]. These strategies may contribute to the long-term management of these conditions [34], improve 107 
adherence [35] and promote a healthy lifestyle in the patients. 108 
The aim of this pilot study was therefore to investigate the efficacy of low-frequency self- 109 
administered VT for neck pain, disability and pressure pain thresholds (PPT) in patients with non-specific 110 
neck pain and MTrPs. We hypothesized that patients receiving VT would report lower levels of perceived 111 
neck pain and disability and present higher PPTs after receiving VT when compared with a no-treatment 112 
control group (CG). 113 
 114 
2. METHODS 115 
2.1. Participants 116 
Subjects between 18 and 45 years old with a history of chronic non-specific neck pain were 117 
invited to participate in this study. Recruitment was performed by advertisement by the University of 118 
Valencia (Spain), from September 2014 to December 2019. Besides having a history of neck pain lasting 119 
three months or more over the previous year, subjects were required to have a Neck Disability Index 120 
(NDI) score of ≥ 5/50 [36] and have active or latent MTrPs in the upper trapezius or levator scapulae 121 
muscles. Both active and latent MTrPs were considered, as latent MTrPs have been associated with the 122 
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development of sensorimotor dysfunction and can contribute to different chronic musculoskeletal pain 123 
disorders [19, 37]. Subjects were excluded if they had had previous cervical spine surgery, cervical 124 
radiculopathy as diagnosed by their primary care physician, a severe systemic disease (e.g. neurological 125 
disorders, inflammatory diseases), diagnosis of fibromyalgia, or other widespread musculoskeletal pain 126 
syndromes (e.g. chronic fatigue syndrome). Patients were also excluded if they had been regularly treated 127 
with analgesic medication or physiotherapy within the previous four weeks.  128 
Approval for the study was granted by the Institutional Ethics Committee (University of 129 
Valencia, Spain), and the procedures were conducted according to the Declaration of Helsinki. The study 130 
was registered on the clinical trials database with number NCT02393521. Written informed consent was 131 
provided before participation. 132 
2.2. Study Design 133 
This study was a randomized controlled clinical trial, with parallel groups and a blinded assessor. 134 
It was undertaken in accordance with the CONSORT statement. Patients were randomly allocated to the 135 
treatments by a non-stratified block randomization with randomly varying block lengths. They were 136 
randomized into two groups: a VT group (VG) and a control group (CG), receiving no treatment. 137 
Randomization was conducted by an external clinical assistant using a random number generator in the 138 
Statgraphics Centurion XVI software (StatPoint Technologies, Inc. Warrenton, USA). On this basis, the 139 
assistant prepared sealed, sequentially numbered envelopes containing the treatment assignments. After 140 
baseline assessment, the study physician opened the lowest numbered envelope to reveal that patient’s 141 
assignment 142 
The outcome measurements for this study were patient-reported levels of pain and disability 143 
rated by the NDI and PPT at active/latent MTrPs of the upper trapezius, and levator scapulae. They were 144 
recorded bilaterally at four assessment times: at baseline (T0), after the first (T1) and fifth (T5) sessions 145 
of treatment and after 10th and final session (T10). 146 
2.3. Procedure 147 
Demographic and anthropometric data of each patient were recorded. Subjects who met the 148 
study requirements completed the NDI questionnaire and were then examined to detect the presence of 149 
active/latent MTrPs in the upper trapezius and levator scapulae, and PPTs were measured at these points. 150 
The presence of MTrPs was determined using the diagnostic criteria described by Simons et al. [1]: 1) 151 
presence of a palpable taut band in the muscle; 2) presence of a hypersensitive tender spot in the taut 152 
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band; 3) palpable or visible local twitch response with snapping palpation of the taut band. Moreover, 153 
participants were evaluated to determine whether the MTrPs were active or latent, with a local 154 
compression in order to stimulate the MTrPs [38]. Active MTrPs were identified if stimulation 155 
reproduced any symptom experienced by the patient, either partially or completely, whereby the symptom 156 
was recognized as a familiar experience by the patient, even though it may not be present at the moment 157 
of the examination. Latent MTrPs were determined when stimulation did not reproduce any symptom 158 
experienced by the participant and he/she did not recognize the elicited symptom as familiar. 159 
Patients in the VG received 10 self-applied sessions of VT. Subjects in the CG did not receive VT. They 160 
were assessed at the same points in time as the VG. Data collection was performed at the University of 161 
Valencia. 162 
Neck Disability Index (NDI) 163 
The NDI questionnaire is a clinical tool designed to assess perceived pain and disability in 164 
patients with neck pain [36, 39]. It consists of a total of 10 items, each with six possible choices 165 
representing everyday activities. The NDI is a valid, reliable, and sensitive tool for measuring changes in 166 
pain and disability in patients with neck pain [39]. This study used the Spanish version of the NDI 167 
validated by Andrade et al [40]. NDI scores were recorded only at T0, T5 and T10. 168 
Pressure pain threshold (PPT) measurement  169 
PPT measurement was conducted bilaterally for four MTrPs in each subject: active or latent 170 
MTrPs of the upper trapezius (MTrP2) and levator scapulae (attachment MTrP) according to Simons et al. 171 
[1] (Figure 1). PPTs were measured with an analogue algometer (Force Dial model FDK 20, Wagner 172 
Instruments, Greenwich, CT, USA) with a surface area at the round tip of 1 cm2. For this purpose, 173 
participants were placed in a sitting position, with their arms resting on the armrests. The algometer tip 174 
was applied perpendicularly to the skin at a rate of 0.98 N/cm2 per second. This measurement was 175 
repeated three times at each point with a 30-second rest period between each measurement, and the mean 176 




Figure 1. PPT assessment and upper trapezius (A) and levator scapulae (B) MTrP locations. 179 
 180 
A familiarization phase preceded the formal measurements, where participants were instructed 181 
on the procedure. Subjects practiced the procedure with the examiner at a remote site (forearm). Subjects 182 
were instructed to indicate the moment when pressure changed to pain, which corresponds to the 183 
definition of the PPT. They were told repeatedly that recording the first sensation of pain was the aim and 184 
not tolerance to pressure [41]. The same researcher performed the PPT measurements on all subjects and 185 
was blinded to the group assignment of the subject. Participants were not informed of their scores to 186 
prevent subject bias from influencing the results. 187 
Pressure algometry is a valid and reliable method for PPT measurement in both healthy [42] and 188 
symptomatic subjects [43, 44], with studies showing good repeatability of measurements on the neck 189 
muscles [44]. The interrater and one-week test-retest reliability of pressure algometry in the neck has 190 
been demonstrated recently (intraclass correlation coefficient (ICC): .75-.95) [45]. 191 
Vibration therapy  192 
VT was applied through a technical device designed for self-application in the home (Shindo®, 193 
Colchones Delax SL, L’Alcúdia, Spain). The vibration device consisted of 10 micro-electric motors, each 194 
of them equipped with an eccentric mass in order to provide an oscillatory pulse (Figure 2 left). Although 195 
the motors worked at 80 Hz, they were connected during 12 ms out of every 20 ms, thus providing a 196 
perceived frequency of 35-50 Hz, corresponding to the commonly used values used for treatment or 197 
prevention of DOMS [24, 28, 46] and to improve muscle relaxation [47]. To avoid friction with the user 198 
or the cover, the motors were enclosed in a plastic capsule with rounded surfaces. These capsules were 199 
placed inside a 32 kg high-density polyurethane mattress, with 2 cm of foam between the patient’s body 200 
and the capsule. During the VT, only the cervical region (two motors) was switched on (Figure 2 right). 201 
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Subjects were able to select, through a wireless controller (Figure 2 left), one of four amplitudes of 202 
vibration (between 7 and 10G). The objective of this was to allow patient control over the intensity of the 203 
vibration in order to ensure their comfort with the treatment. The following instructions were provided to 204 
the subject: "Choose a level of intensity that is comfortable for you. You should perceive a gentle 205 
vibration sensation on your cervical area".  206 
Subjects receiving VT (VG) were instructed to self-administer this therapy for 10 sessions, one 207 
session per day, lying on their mattress at home in the supine position for 15 minutes. [28] Participants 208 
were requested not to use any other specific treatments for their neck pain, although their usual 209 
medication was not withdrawn.  210 
Control group 211 
Subjects  in the CG did not receive a comparable treatment, as no treatment was applied to them. 212 
They were instructed to lie on a conventional mattress without vibration effect at home, in the supine 213 
position, during the same time frame as the VG (i.e.: 15 minutes once a day during 10 days). Participants 214 
were requested not to use any other specific treatments for their neck pain, although their usual 215 




Figure 2. (Left): motors used in the vibration device. (Right): wireless controller used by the 218 
subjects and location of the micro-electric motors. 219 
2.4. Data analysis. 220 
First, a one-way ANOVA with significance level of differences set at p<.05 was conducted to 221 
evaluate if initial differences appeared between resulting groups after the randomized assignment. The 222 
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total PPT and NDI were selected as the dependent variables and the group as the factor including two 223 
levels: VG and CG. 224 
In order to compare the treatment evolution between VG and CG, multiple univariate ANOVA 225 
were conducted with significance levels of differences set at p<.05. A one-way ANOVA was performed 226 
at each step of the treatment (T0, T1, T5, and T10) with total PPT and NDI as dependent variables and 227 
with resulting groups as the factor. The mean values and 95% CI were also calculated. The η2 value was 228 
calculated to measure the effect size. 229 
Finally, to analyse the evolution within subjects belonging to the VG, Friedman’s ANOVA 230 
analysis was conducted. Total PPT for T0, T1, T5 and T10 and DNI for T0, T5 and T10 were compared 231 
with significance levels of differences set at p<.05. Post hoc Wilcoxon test were performed for each pair 232 
of variables with a Bonferroni adjustment (multiplying p-values from the Wilcoxon tests by the number 233 
of Wilcoxon tests being carried out in each case) to assure confidence level correction and identify 234 
between which pair of levels of the factor variable the differences appeared. Kendall’s W was calculated 235 
to measure the effect size.  236 
All data analyses were performed using the SPSS 16 statistical application for Windows. 237 
3. RESULTS 238 
Thirty-eight subjects were screened for possible eligibility criteria, and 22 subjects successfully 239 
completed the study protocol (VG n=11, CG n=11). Figure 3 shows a flow diagram representing the 240 
subject process of recruitment and dropouts. The baseline characteristics of the final sample are 241 





Figure 3. CONSORT flow diagram of subject recruitment throughout the course of the study. 245 
 246 
Neck Disability Index (NDI) and pressure pain threshold (PPT) 247 
There were no differences in NDI or in total PPT between CG and VG at T0, as shown in 248 
Figures 4 and 5. Moreover, Figure 4 shows the results of the ANOVAs carried out to analyse the 249 
evolution of NDI differences between CG and VG along the treatment, showing significant differences 250 
between groups in T10, in which VG reached lower values than CG. Likewise, Figure 5 shows the results 251 
of the ANOVAs carried out to analyse the evolution of total PPT differences between CG and VG along 252 
the treatment, showing significant differences again between groups in T10, in which VG reached greater 253 




Figure 4. Comparison of NDI between CG and VG along the treatment. 256 
 257 
Figure 5. Comparison of total PPT (N/cm2) between CG and VG along the treatment. 258 
Regarding analysis among subjects belonging to the VG group, Friedman’s ANOVAs carried out 259 
for total PPT and NDI showed significant differences between steps of the treatment. χ2 values, 260 
significance and Kendall’s W values are shown in Table 2. 261 




Post hoc Wilcoxon multiple comparison tests results are shown in Table 3. As shown in Table 3, 264 
there are significant differences between all pairs of steps for PPT, with increasing values along the 265 
treatment (as the number of sessions increased). Similarly, for NDI there were significant differences 266 
between all pairs of steps, with decreasing values along the treatment (as the number of sessions 267 
increased). 268 
 269 
4. DISCUSSION 270 
 To our knowledge, this is the first randomized controlled study investigating the effect of VT on 271 
pressure pain sensitivity at cervical MTrPs and self-reported neck pain and disability in people with 272 
chronic non-specific neck pain. In this study, patients treated with self-applied mechanical VT showed a 273 
significant reduction in neck pain and disability and an increase in PPT at cervical MTrPs, compared to a 274 
CG, which did not receive a comparable treatment, while not receiving any intervention. Interestingly, 275 
improvements in pressure pain sensitivity and in neck pain and disability with VT increased as treatment 276 
progressed. Higher improvements in PPT and in NDI values were observed at the end of 10 sessions of 277 
VT.  278 
 Regarding the NDI results over the course of treatment, the mean reduction in NDI scores in the 279 
vibration group was 4.52 points between T10 and T0 (i.e., end of intervention) and 2.50 points between 280 
T5 and T0 (i.e., half of intervention period). The mean improvement expressed as a percentage of the 281 
initial NDI value was 44.15% and 24.39% respectively. Hence, the NDI score at the midpoint of the 282 
intervention period is well above the 10% level stated by MacDermid et al. [49] as the minimal detectable 283 
change, which demonstrates the importance of our results. The improvement observed in the NDI in this 284 
study is comparable to the improvements reported when other conservative modalities of treatment 285 
involving some form of vibration, such as cupping [50] or massage [51], were employed in people with 286 
chronic non-specific neck pain. This could suggest that vibration methods, regardless of the specific 287 
modality, may be effective for the treatment of pain and disability in patients with chronic non-specific 288 
neck pain. Further studies with larger neck pain populations should explore these promising new avenues 289 
of treatment. 290 
 Treatment effects were also observed for VT on PPT. The increase in PPT with VT was 291 
observed from the very first treatment in the VG subjects. After the first session, the increase at cervical 292 
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MTrPs was 1.46 N/cm2. After five sessions, the increase reached 5.34 N/cm2, and after 10 sessions 8.54 293 
N/cm2. Except for the first value, these scores exceed those proposed by Walton et al. [52] for the 294 
minimum detectable change. This means that only the increase observed between T0 and T1 could be 295 
attributed to the standard error of measurement. Furthermore, higher PPT differences were observed in 296 
the VG when compared to the CG at the end of the intervention period (1.96 N/cm2 of difference at T1, 297 
5.33 N/cm2 at T5 and 8.28 N/cm2 at T0). Improvements achieved with VT in the VG occurred in a 298 
continuous fashion throughout the treatment period, with stronger effects as the treatment progressed. 299 
This behaviour could be attributable to the possible cumulative effects of the VT sessions [53]. 300 
Nevertheless, caution should be taken when interpreting the differences obtained between VG and CG 301 
because, although they could be due to the specific effects of the VT, they could also be caused by 'non-302 
specific' factors, such as placebo or patient expectations [54]. In clinical research, it is very difficult to 303 
control for all possible confounding variables, and, once these ‘non-specific’ factors are stripped away 304 
[54, 55], any intervention as a stand-alone treatment is of questionable efficacy [56].  305 
Only short-term changes in PPT at MTrPs have been reported by previous studies [10, 50]. The 306 
linear trend on PPT as observed in our results seems to indicate that PPT improvement would continue to 307 
increase with a greater number of sessions. Further studies are necessary to confirm these preliminary 308 
results in order to evaluate the long-term effects of VT on PPT.  309 
Positive effects on PPT at cervical MTrPs have been previously reported in the literature when 310 
applying different modalities of treatment. Therapies such as ischemic compression [10, 12], cupping 311 
[50], dry needling [12, 15], or spinal thrust manipulation [57] have demonstrated positive effects on PPT 312 
at MTrPs located in the cervical region. However, other self-management strategies such as therapeutic 313 
exercise have also been identified as beneficial for people with neck pain. According to the results of a 314 
recent systematic review [58], the use of specific strengthening exercises, whether isolated or combined 315 
with endurance or stretching exercises as a part of routine practice, have been shown to be an effective 316 
approach for people suffering from neck pain. 317 
Although the underlying mechanisms of pain relief were not specifically addressed in this study, 318 
some discussion is warranted. VT may have exerted its effects by local mechanisms, such as increasing 319 
blood flow [26, 46] or normalizing the length of sarcomeres [11], which are two proposed mechanisms of 320 
action for interventions in MTrPs [11]. Besides, mechanical stimulation resulting from the application of 321 
VT may have activated Aβ fibres and consequently led to a segmental inhibition at the spinal cord level 322 
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via the gate control mechanism. Based on gate control hypothesis [59], it could be inferred that vibration 323 
strongly impacts upon afferent discharges from fast adapting mechanoreceptors and muscle spindles and 324 
hence acts as an effective pain reliever. As VT is a painless procedure, descending pain modulation 325 
mechanisms should not, in theory, come into action, although their effects should not be ignored. Another 326 
possible explanation with regard to pain relief mechanisms may be found in mechanotransduction 327 
theories. It is accepted that the mechanism of action of vibration treatment involves some form of 328 
mechanotransduction, which refers to the conversion of a mechanical force into a cellular and molecular 329 
response [60]. These cellular responses, in turn, promote structural change through tissue repair and 330 
remodelling [61]. However, although the adaptive ability of tissues in response to mechanical stimuli has 331 
long been established, the precise mechanisms underlying the response at the cellular and molecular 332 
levels have only recently begun to be unravelled identified and remain to be fully elucidated [60]. Muscle 333 
tissue is highly responsive to changes in functional demands through the modulation of load-induced 334 
pathways [61]. Nevertheless, the clinical application of mechanotherapy for muscle injury is based on 335 
animal studies [62], so conclusions should be reached with caution.  336 
It is known that MTrPs in the neck and shoulder muscles may play an important role in the 337 
genesis of mechanical neck pain, or contribute to pain symptoms in individuals with mechanical neck 338 
pain [63]. Moreover, persistence of MTrPs in neck muscles can result in headache, dizziness, limited 339 
range of motion in the neck, muscle weakness, abnormal sensation, autonomic dysfunction, and disability 340 
[64]. Treatment of myofascial pain is based on inactivating the MTrPs. The most common conservative 341 
interventions for this purpose are ischemic compression and dry needling [65, 66]. However, to the best 342 
of our knowledge, VT has never been employed as a treatment alternative for MTrPs. Consequently, our 343 
results are not comparable with previous studies. Nevertheless, VT was found to be effective for 344 
treatment and prevention of DOMS [24, 28, 67]. An important overlap between the physiopathological 345 
mechanisms of eccentric contraction, which induces DOMS, and the development of MTrPs has been 346 
suggested [68], but future studies should compare the effectiveness of VT in people with DOMS and 347 
MTrPs to see if effects are comparable.  348 
 349 
4.1. Limitations  350 
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There are some limitations to our study that should be acknowledged. First of all, the obtained 351 
findings may be somewhat limited by the sample size. While the number of subjects allowed finding 352 
significant differences between VG and CG, and within the VG along the treatment, the sample size 353 
effect is moderate in one-way ANOVAs performed at T10 (0.04 < η2 ≤ 0.36). This limited sample size 354 
could reduce the generalizability of our findings to the general population. A greater sample size, which 355 
increases variability, could strengthen the magnitude of effect, as well as enable the comparison of results 356 
between different muscles or subject characteristics, such as gender or age. Further studies including 357 
more patients are therefore recommended. Secondly, since non-specific effects were not strictly 358 
controlled for this study, they should not be overlooked. Future studies should take into account 359 
confounding factors such as placebo, patient expectations or possible central sensitization patterns. 360 
Finally, as only the trapezius and levator scapulae muscles were considered in this study, our findings 361 
cannot be extrapolated to other locations. Future studies should further explore the effect of VT in other 362 
body regions/muscles. More research is also needed to determine long-term effects of VT.  363 
 364 
5. CONCLUSIONS 365 
 This pilot study shows that 10 sessions of self-administered VT using 35-50 Hz frequency ranges 366 
improved pressure pain sensitivity over trapezius and levator scapulae MTrPs and self-reported neck pain 367 
and disability in patients with chronic non-specific neck pain. Further large population studies are needed 368 
to determine the true efficacy of VT. Thus, self-applied VT may be an effective intervention for releasing 369 
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*Values are mean (SD) or as otherwise indicated. 656 
  657 




Age (years) 34.57 (6.21) 31.36 (10.79) 
Sex (n male/n female) 6/5 3/8 
NDI (0-50) 8.75 (3.80) 7.5 (4.58) 
PPT 
(N/cm2) 
trapezius painful side 32.65 (16.59) 32.23 (9.92) 
trapezius non-painful side 30.00 (13.80) 29.09 (5.56) 
levator scapulae painful side 38.17 (18.60) 34.80 (10.57) 
levator scapulae non-painful side 36.40 (16.77) 32.44 (8.70) 
27 
 
Table 2. χ2 values, significance and Kendall’s W values for Friedman’s ANOVAs 658 
  NDI Total PPT (N/cm2) 
χ2 19.35 87.10 
Sig. 0.000 0.000 
Kendall’s W 0.28 0.73 
  659 
28 
 
Table 3. Significant differences in NDI and total PPT (N/cm2) from Wilcoxon comparison tests for steps 660 
treatment (after applying Bonferroni adjustments in p-values). 661 
 662 
NDI  Total PPT (N/cm2)  
Treatment Step Z value  Treatment Step Z value  
(I) (J) (I) − (J)  (I) (J) (I) − (J)  
T10 T0 -4.735***  T10 T0 -5.425***  
 
T5  -2.744***    T1 -5.055***  
T5 T0 -2.218**    T5 -3.455***  
    T5 T0 -5.174***  
     T1 -5.132***  
    T1 T0 -3.399***  
*** p < 0.001. ** p < 0.05. 663 
 664 
 665 
